Halodoc Receives $65 Million Series-B Funding

6 months ago . 1 min read
EC
Ester Christine Natalia
Senior Writer at Forbes Indonesia
Halodoc Receives $65 Million Series-B Funding
Jonathan Sudharta, Halodoc Founder and CEO. (Photo credit: Adik Subagio for Forbes Indonesia)

Indonesia leading digital health application Halodoc just received $65 million Series-B funding led by UOB Venture Management, a subsidiary of Singapore lender UOB. Other new investors join the line include Singtel Innov8, Korea Investment Partners and WuXi AppTec.

Halodoc plans to use the investment to further develop its services technology and infrastructure. It will also increase number of strategic partnerships with hospitals and insurance providers in Indonesia this year. So far, the platform has partnered with over 1,400 hospitals throughout Indonesia.

“We see a huge potential in utilizing technology to expand conventional health services, as well as providing better access to health services for Indonesians. This strategic investment and partnership enable us to accelerate our effort in developing digital platform to increase access and convenience to health services for millions of users in Indonesia,” says Jonathan Sudharta, Halodoc Founder and CEO, in a statement today.

Jonathan founded Halodoc in 2016 to provide convenient health services through technology. It connects about 2 million users with more than 20,000 licensed doctors in across Indonesia using online chatting on smartphone and website. The platform also enables users to order medicine from 1,300 drugstores and receive it within an hour, as well as to book laboratory check.

With the available services, Halodoc seeks an opportunity to get big slices from Indonesia health industry, which value is expected to reach $21 trillion in 2019 according to market research company Frost and Sullivan.

Halodoc claims that the use of its platform has surpassed the expectation by surging up to 2,500% in 2018. For its contribution in transforming health sector with technology, health-tech advisory firm Galen Growth Asia awarded Halodoc as the Most Innovative Start-up in Asia in November 2018.

“Our investment in Halodoc reflects an approach of responsible investment to support the economic and social improvement,” says Kian-Wee Seah, Managing Director and CEO UOB Venture Management.

EC
Written By
Ester Christine Natalia
Senior Writer at Forbes Indonesia
Topics
Invesment